期刊文献+

依托考昔致固定性药疹国内首报及文献复习 被引量:5

The first case of fixed drug eruption caused by etoricoxib in China and related references review
在线阅读 下载PDF
导出
摘要 报道1例依托考昔致固定型药疹患者,男,43岁。因眼内眦、唇部、颊黏膜及龟头红斑、水疱、糜烂,伴痛痒12 h就诊。查体见双眼内眦皮肤小片淡红斑;双唇见大片水肿性红斑或紫红斑,少许水疱,口腔颊黏膜见小片状水肿性红斑;龟头部见大片红斑、糜烂和渗液。既往有3次口服依托考昔后均出现过类似皮损病史。据此诊断为固定型药疹(依托考昔所致)。患者停用依托考昔,经抗过敏与对症治疗后皮损逐渐消退,局部遗留持久性色素沉着斑。警示临床医师应注意依托考昔所致固定型药疹的皮肤不良反应。 A case of fixed drug eruption caused by etoricoxib was reported here. A 43-year-old male presented with erythema, blisters, erosions on the skin of his inner canthi, mucosal membranes of the lips, oral as well as the balanus, accompanied by pruritus and pain for 12 hours. Dermatologic examination showed small pale erythema on his inner canthi; large violaceous or edematous erythema with several blisters were seen on his lips; small edematous erythema on the buccal mucosa; large erythema, erosions and exudation on his balanus. The patient had had three episodes with similar skin lesions after taking etoricoxib this time before. Then he was diagnosed as fixed drug eruption caused by etoricoxib. After etoricoxib was withdrawn and antihistamines as well as symptomatic treatment were adopted, the skin lesions resolved gradually, as well as long-last residual hyperpigmentation leaved. This case alerts clinicians to pay attention to the adverse reaction of fixed drug eruption caused by etoricoxib.
出处 《实用皮肤病学杂志》 2015年第6期419-421,共3页 Journal of Practical Dermatology
关键词 药疹 固定性 依托考昔 Fixed drug eruption: Etoricoxib
作者简介 董盈盈,硕士研究生,研究方向:分子皮肤病学,E—mail:839463210@qq.com 通讯作者:邓云华,E—mail:yhdeng@tjh.tjmu.edu.cn
  • 相关文献

参考文献15

  • 1Brahimi N, Routier E, Raison-Peyron N, et al. A three-year-analysis of fixed drug eruptions in hospital settings in France [J]. Eur J Dermatol, 2010, 20(4):461-464.
  • 2Andrade P, Brinca A, Gonqalo M. Patch testing in fixed drug eruptions-a 20-year review [J]. Contact Dermatitis, 2011, 65(4): 195-201.
  • 3Heng YK, Yew YW, Lira DS, et al. An update of fixed drug eruptions in Singapore [J]. J Eur Acad Dermatol Venereol, 2015, 29(8): 1539-1544.
  • 4Venturini Diaz M, San Juan de la Parra S, Segura Arazuri N. Selective immediate hypersensitivity to etoricoxib [J]. J lnvestig Altergol Clin lmmunol, 2008, 18(6):485-487.
  • 5Makela L, Lammintausta K. Etoricoxib-induced acute generalized exanthematous pustulosis [J]. Acta Derm Venereol, 2008, 88(2):200-201.
  • 6Thirion L, Nikkels AF, Pirard GE. Etoricoxib-induced erythema- multiforme-like eruption [J]. Dermatology, 2008, 216(3):227-228.
  • 7Kreft B, Wohlrab J, Bramsiepe I, et al. Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab [J]. J Dermatol, 201 O, 37( 10 ):904-906.
  • 8Augustine M, Sharma P, Stephen J, et al. Fixed drug eruption and generalised erythema following etoricoxib [J]. Indian J Dermatol Venereol Leprol, 2006, 72(4):307-309.
  • 9Duarte AF, Correia O, Azevedo R, et al. Bullous fixed drug eruption to etoricoxib-further evidence of intraepidermal CD8'T cell involvement [J]. Eur J Dermatol, 2010, 20(2):236-238.
  • 10Calistru AM, Cunha AP, Nogueira A, et al. Etoricoxib-induced fixed drug eruption with positive lesional patch tests [J]. Cutan Ocul Toxicol, 2011, 30(2):154-156.

二级参考文献16

共引文献10

同被引文献18

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部